Insulin secretagogues with an imidazoline structure inhibit arginine-induced glucagon secretion from isolated rat islets of langerhans

Biochemical and Biophysical Research Communications

Volumn 236, Issue 1, 1997, Pages 162-166

  Mourtada, Mirna ^a   Smith, Stephen A ^b   Morgan, Noel G ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTAZOLINE; ARGININE; CELL RECEPTOR; EFAROXAN; GLUCAGON; GLUCOSE; IDAZOXAN; IMIDAZOLINE DERIVATIVE; INSULIN; PHENTOLAMINE; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GLUCAGON RELEASE; HORMONE RELEASE; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031561144     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6922     Document Type: Article

References (29)

1. Reis D. J., Bousquet P., Parini A. Ann. N.Y. Acad. Sci. 763:1995;1-707.
2. Regunathan S., Reis D. J. Ann. Rev. Pharmacol. Toxicol. 36:1996;511-544.
3. Bousquet P. J. Cardiovasc. Pharmacol. 26:1995;S1-S6.
4. Michel M. C., Ernsberger P. Trends Pharmacol. Sci. 13:1992;369-370.
5. Chan S. L. F. Clin. Sci. 85:1993;671-677.
6. Morgan N. G. Exp. Opin. Invest. Drugs. 3:1994;561-569.
7. Chan S. L. F., Dunne M. J., Stillings M. R., Morgan N. G. Eur. J. Pharmacol. 204:1991;41-48.
8. Dunne M. J. Br. J. Pharmacol. 103:1991;1847-1850.
9. Jonas J-C., Plant T. D., Henquin J-C. Br. J. Pharmacol. 107:1992;8-14.
10. Schulz A., Hasselblatt A. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;637-643.
11. Shepherd R. M., Hashmi M. N., Kane C., Squires P. E., Dunne M. J. Br. J. Pharmacol. 119:1996;911-916.
12. Rustenbeck I., Kowalewski R., Herrmann C., Dickel C., Ratzka P., Hasselblatt A. Exp. Clin. Endocrinol. 103:1995;42-45.
13. Berridge T. L., Doxey j. C., Roach A. G., Smiith C. F. C. Eur. J. Pharmacol. 213:1992;205-212.
14. Mourtada M., Brown C. A., Smith S. A., Piercy V., Chan S. L. F., Morgan N. G. Br. J. Pharmacol. 1997.
15. Kameda K., Ono S., Abiko Y. Arzneim. Forsch. 32:1982;39-44.
16. Broadstone V. L., Pfeifer M. A., Bajaj B., Stagner J. I., Samols E. Diabetes. 36:1987;932-937.
17. Wang X., Rondu F., Lamouri A., Dokhan R., Marc S., Touboul E., Pfeiffer B., Manechez D., Renard P., Guardiola-Lemaitre B., Godfroid J-J., Ktorza A., Penicaud L. J. Pharmacol. Exp. Ther. 278:1996;82-89.
18. Kawazu S., Suzuki N., Watanabe T., Ishii J. Diabetes. 36:1987;216-220.
19. Efanova I. B., Zaitsev S. V., Efanov A. M., Ostenson C-G., Berggren P-O., Efendic S. Diabetologia. 39:1996;A235.
20. Chan S. L. F., Morgan N. G. Eur. J. Pharmacol. 176:1990;97-101.
21. Schulz A., Hasselblatt A. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;321-327.
22. Berdeu D., Gross R., Ribes G., Loubatieres-Mariani M-M., Bertrand G. Eur. J. Pharmacol. 254:1994;119-125.
23. Berdeu D., Gross R., Puech R., Loubatieres-Mariani M-M., Bertrand G. Eur. J. Pharmacol. 275:1995;91-98.
24. Ernsberger P. R., Westbrooks K. L., Christen M. O., Schafer S. G. J. Cardiovasc. Pharmacol. 20:1992;S1-S10.
25. Chan S. L. F., Perrett C. W., Morgan N. G. Cell. Signalling. 9:1997;71-78.
26. Hirose H., Maruyama H., Itoh K., Koyama K., Kido K., Saruta T. Acta Endocrinol. 127:1992;279-283.
27. Zaitsev S. V., Efanov A. M., Efanova I. B., Larsson O., Ostenson C-G., Gold G., Berggren P-O., Efendic S. Diabetes. 45:1996;1610-1618.
28. Chan S. L. F., Pallett A. L., Clews J., Ramsden C. A., Morgan N. G. Eur. J. Pharmacol. 323:1997;241-244.
29. Aguiler-Bryan L., Nichols C. G., Wechsler S. W., Clement J. P., Boyd A. E., Gonzalez G., Herrera-Sosa H., Nguy K., Bryan J., Nelson D. A. Science. 268:1996;423-426.